ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

News Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:28 23/01/2026 pm IST			5-day change	1st Jan Change
0.7800 ^HKD	+5.41%		+9.86%	+39.29%

23/01	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025	CI
23/01	Zhongzhi pharmaceutical expects over 70% decrease in 2025 net profit	RE

23/01	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025	CI
23/01	Zhongzhi pharmaceutical expects over 70% decrease in 2025 net profit	RE
26/25/26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/25/18	Zhongzhi pharmaceutical expects 90% decrease in HY net profit	RE
18/25/18	Zhongzhi Pharmaceutical Warns of 90% Drop in H1 Profit	MT
18/25/18	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2025	CI
13/25/13	Zhongzhi Pharmaceutical Holdings Limited Approves Dividend	CI
10/25/10	Zhongzhi Pharmaceutical Holdings Limited Announces Board and Committee Changes, Effective 10 April 2025	CI
26/25/26	Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2024, Payable on 19 June 2025	CI
26/25/26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/25/17	Zhongzhi Pharmaceutical Expects Profit to Plunge 45% in 2024	MT
17/25/17	Zhongzhi Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2024	CI
24/24/24	Zhongzhi Pharmaceutical Invests in US Biotech Firm to Advance Alzheimer's Treatment	MT
06/24/06	Zhongzhi Pharmaceutical Holdings Plans to Unwind Contractual Agreements to Directly Hold Control Over Subsidiary	MT
09/24/09	Zhongzhi Pharmaceutical Holdings Limited Announces Resignation of Peng Zhiyun as Non-Executive Director	CI
23/24/23	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	CI
12/24/12	Zhongzhi Pharmaceutical Warns of 40% Drop in H1 Profit	MT
12/24/12	Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2024	CI
17/24/17	Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend	CI
25/24/25	Zhongzhi Pharmaceutical's Attributable Jumps in 2023	MT
22/24/22	Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024	CI
22/24/22	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
26/24/26	Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit	MT
25/24/25	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	CI
13/23/13	Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Filters